Eli Lilly's CEO is ‘disappointed’ that only 1 in 10 Americans are on GLP-1s

Semafor Semafor

“We look at that as disappointing on the one hand because our job is to get medicines to patients,” Eli Lilly CEO David Ricks said at Semafor World Economy.

Read full article at Semafor →